Target intelligence / Profile preview

Actin polymerization

Molecular classification
Other (biochemical process; sometimes ascribed to "Cytoskeletal protein polymerization"), Enzyme, Actin-binding protein
01

Overview

Actin polymerization is a rapid, ATP-dependent cellular process by which actin monomers (G-actin) assemble into polar, double-helical filaments (F-actin), which underpin the cytoskeleton and drive essential functions such as cell movement, shape change, division, and intracellular transport[2][3]. Nucleation is rate-limiting but overcome in vivo by actin-nucleating factors (e.g., Arp2/3 complex for branching, formins for linear extension). Polymerization is tightly regulated by actin-binding proteins such as profilin (assists ATP-actin addition), cofilin (promotes ADP-actin removal and filament severing), gelsolin (severs filaments and caps ends), and thymosin β4 (sequesters actin monomers)[1][2][3][4]. Drugs and toxins can disrupt or stabilize actin polymerization, affecting cellular functions, which is exploited in research and sometimes targeted in disease, though systemic modulation carries high toxicity risks. Actin polymerization dysfunction plays roles in cancer, neurodegeneration, cardiovascular and infectious diseases[2][3][4].

Other names
F-actin formationactin filament assemblyactin network formationactin treadmilling
02

Mechanism of action

Inhibition of actin filament assembly (cytochalasin D, latrunculin); Stabilization of actin filaments (phalloidin, jasplakinolide); Modulation of actin-binding protein activity (formins, Arp2/3 complex, cofilin)

03

Biological functions

Cytoskeleton organizationCell motilityCell shape regulationCell division (contractile ring assembly)Signal transductionEndocytosisIntracellular transport
04

Disease associations

Cancer (metastasis, invasion)Neurodegenerative disease (cytoskeletal disruption)Cardiovascular disease (vascular remodeling)Infection (cellular entry by pathogens)Other (immune cell migration, developmental disorders, myopathies)
05

Safety considerations

General cytotoxicity (disruption of actin affects all eukaryotic cells; high risk for systemic toxicity)Off-target effects (affects muscle contraction, cell division, immune function)Cardiotoxicity, myopathy, impaired wound healing
06

Interacting drugs

Cytochalasin D (inhibits actin polymerization)

4 more in the full profile.

07

Biomarkers

F-actin/G-actin ratio (dynamic actin turnover indicator in tissue/cells)Expression levels of actin-binding proteins (e.g., cofilin phosphorylation as marker of actin dynamics in cancer)Cellular morphology (e.g., lamellipodia/filopodia in migration assays)

Beyond the preview

Go deeper on Actin polymerization.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Actin polymerization.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call